These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7902092)

  • 1. Sulfasalazine in early rheumatoid arthritis. A 48-week double-blind, prospective, placebo-controlled study.
    Hannonen P; Möttönen T; Hakola M; Oka M
    Arthritis Rheum; 1993 Nov; 36(11):1501-9. PubMed ID: 7902092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulfasalazine in rheumatoid arthritis. A double-blind, placebo-controlled trial.
    Pinals RS; Kaplan SB; Lawson JG; Hepburn B
    Arthritis Rheum; 1986 Dec; 29(12):1427-34. PubMed ID: 2879544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with leflunomide slows radiographic progression of rheumatoid arthritis: results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group.
    Sharp JT; Strand V; Leung H; Hurley F; Loew-Friedrich I
    Arthritis Rheum; 2000 Mar; 43(3):495-505. PubMed ID: 10728741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: results of a two-year, randomized, double-blind, placebo-controlled trial.
    O'Dell JR; Leff R; Paulsen G; Haire C; Mallek J; Eckhoff PJ; Fernandez A; Blakely K; Wees S; Stoner J; Hadley S; Felt J; Palmer W; Waytz P; Churchill M; Klassen L; Moore G
    Arthritis Rheum; 2002 May; 46(5):1164-70. PubMed ID: 12115219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfasalazine in the treatment of juvenile chronic arthritis: a randomized, double-blind, placebo-controlled, multicenter study. Dutch Juvenile Chronic Arthritis Study Group.
    van Rossum MA; Fiselier TJ; Franssen MJ; Zwinderman AH; ten Cate R; van Suijlekom-Smit LW; van Luijk WH; van Soesbergen RM; Wulffraat NM; Oostveen JC; Kuis W; Dijkstra PF; van Ede CF; Dijkmans BA
    Arthritis Rheum; 1998 May; 41(5):808-16. PubMed ID: 9588731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulfasalazine in the treatment of spondylarthropathy. A randomized, multicenter, double-blind, placebo-controlled study.
    Dougados M; vam der Linden S; Leirisalo-Repo M; Huitfeldt B; Juhlin R; Veys E; Zeidler H; Kvien TK; Olivieri I; Dijkmans B
    Arthritis Rheum; 1995 May; 38(5):618-27. PubMed ID: 7748217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulfasalazine treatment for rheumatoid arthritis: a metaanalysis of 15 randomized trials.
    Weinblatt ME; Reda D; Henderson W; Giobbie-Hurder A; Williams D; Diani A; Docsa S
    J Rheumatol; 1999 Oct; 26(10):2123-30. PubMed ID: 10529127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate in combination with sulfasalazine is more effective in rheumatoid arthritis patients who failed sulfasalazine than in patients naive to both drugs.
    Schipper LG; Fransen J; Barrera P; Van Riel PL
    Rheumatology (Oxford); 2009 Jul; 48(7):828-33. PubMed ID: 19458163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulfasalazine therapy for juvenile rheumatoid arthritis.
    Chen CC; Lin YT; Yang YH; Chiang BL
    J Formos Med Assoc; 2002 Feb; 101(2):110-6. PubMed ID: 12099201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum matrix metalloproteinase 3 levels during treatment with sulfasalazine or combination of methotrexate and sulfasalazine in patients with early rheumatoid arthritis.
    Posthumus MD; Limburg PC; Westra J; van Leeuwen MA; van Rijswijk MH
    J Rheumatol; 2002 May; 29(5):883-9. PubMed ID: 12022344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of sulphasalazine plus methotrexate in rheumatoid arthritis.
    Islam MN; Alam MN; Haq SA; Moyenuzzaman M; Patwary MI; Rahman MH
    Bangladesh Med Res Counc Bull; 2000 Apr; 26(1):1-7. PubMed ID: 11192489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical observation on treatment of rheumatoid arthritis by combined therapy with methotrexate, sulfasalazine and Chinese herbal medicine].
    Lu SJ; Shao J; Li XR
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2002 Aug; 22(8):571-3. PubMed ID: 12572373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study.
    van Halm VP; Nurmohamed MT; Twisk JW; Dijkmans BA; Voskuyl AE
    Arthritis Res Ther; 2006; 8(5):R151. PubMed ID: 16984661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of improvements, full responses, remission and toxicity in rheumatoid patients treated with step-up combination therapy (methotrexate, cyclosporin A, sulphasalazine) or monotherapy for three years.
    Ferraccioli GF; Gremese E; Tomietto P; Favret G; Damato R; Di Poi E
    Rheumatology (Oxford); 2002 Aug; 41(8):892-8. PubMed ID: 12154206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating rheumatoid arthritis early with disease modifying drugs reduces joint damage: a randomised double blind trial of sulphasalazine vs diclofenac sodium.
    Choy EH; Scott DL; Kingsley GH; Williams P; Wojtulewski J; Papasavvas G; Henderson E; Macfarlane D; Erhardt C; Young A; Plant MJ; Panayi GS
    Clin Exp Rheumatol; 2002; 20(3):351-8. PubMed ID: 12102471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Slowing of disease progression in rheumatoid arthritis patients during long-term treatment with leflunomide or sulfasalazine.
    Larsen A; Kvien TK; Schattenkirchner M; Rau R; Scott DL; Smolen JS; Rozman B; Westhovens R; Tikly M; Oed C; Rosenburg R;
    Scand J Rheumatol; 2001; 30(3):135-42. PubMed ID: 11469522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When a DMARD fails, should patients switch to sulfasalazine or add sulfasalazine to continuing leflunomide?
    Dougados M; Emery P; Lemmel EM; Zerbini CA; Brin S; van Riel P
    Ann Rheum Dis; 2005 Jan; 64(1):44-51. PubMed ID: 15271770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High toxicity of sulfasalazine in adult-onset Still's disease.
    Jung JH; Jun JB; Yoo DH; Kim TH; Jung SS; Lee IH; Bae SC; Kim SY
    Clin Exp Rheumatol; 2000; 18(2):245-8. PubMed ID: 10812499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and retention of combination triple disease-modifying anti-rheumatic drugs in new-onset rheumatoid arthritis.
    Cummins L; Katikireddi VS; Shankaranarayana S; Su KY; Duggan E; Videm V; Pahau H; Thomas R
    Intern Med J; 2015 Dec; 45(12):1266-73. PubMed ID: 26384029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A controlled trial comparing sulfasalazine, gold sodium thiomalate, and placebo in rheumatoid arthritis.
    Williams HJ; Ward JR; Dahl SL; Clegg DO; Willkens RF; Oglesby T; Weisman MH; Schlegel S; Michaels RM; Luggen ME
    Arthritis Rheum; 1988 Jun; 31(6):702-13. PubMed ID: 2898244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.